Furthermore, analysis of mammary gland and tumors from VDRKO mice demonstrated that loss of VDR was associated with enhanced HAS2 and HA accumulation in vivo.(22) Thus, vitamin D signaling directly compromises breast cancer stem cell viability and potentially delays tumor progression via interruption of HA‐CD44 survival signaling in the TME. The gene discussed is HAS2; the disease is breast carcinoma.